547P Rucaparib + sacituzumab govitecan (SG): Initial data from the phase Ib/II SEASTAR study (NCT03992131)
| Autor: | Yap, T.A., Hamilton, E.P., Bauer, T.M., Dumbrava, E.E. Ileana, Jeselsohn, R., Enke, A., Hurley, S., Lin, K.K., Wride, K., Giordano, H., Shapiro, G. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S476-S477 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|